Zhongqiang Lin

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University

发表论文 16 篇 · 总被引 187 次 · h-index 8

代表论文

• Quantitative features and clinical significance of two subpopulations of AChR-specific CD4+ T cells in patients with myasthenia gravis (2020 · Clinical Immunology · 被引 40)
• Influence of Drug Properties and Formulation on In Vitro Drug Release and Biowaiver Regulation of Oral Extended Release Dosage Forms (2016 · The AAPS Journal · 被引 36)
• Hospital and healthcare insurance system record–based epidemiological study of myasthenia gravis in southern and northern China (2020 · Neurological Sciences · 被引 27)
• Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients (2020 · Clinical Immunology · 被引 22)
• Leflunomide ameliorates experimental autoimmune myasthenia gravis by regulating humoral and cellular immune responses (2021 · International Immunopharmacology · 被引 18)
• Imbalance of the two main circulating dendritic cell subsets in patients with myasthenia gravis (2018 · Clinical Immunology · 被引 12)